MedTech Resources

PMA device

Lumicell Direct Visualization System (DVS)

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

Breakthrough-designated

Device trials

246

Naming "Direct Visualization"

MAUDE reports

7

Brand "Direct Visualization", since 2015

PubMed studies

8,710

Mentioning "Direct Visualization"

AI summary across all sources

Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "Direct Visualization", any status and sponsor, newest update first.

Open in Trial Radar

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Direct Visualization", and for the whole product code for context.

This brand

7 reports: 4 malfunction, 1 injury, 2 death

Whole product code SAW

0 reports: 0 malfunction, 0 injury, 0 death

Newest reports for this brand

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "Direct Visualization"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.